Encouragingly, we showed that p110α inhibitors promote the suppressive effects of ALK inhibitors in neuroblastoma, so the presence of PI3K inhibitors may help to antagonize the drug resistance of neuroblastoma. This evidence concerns the gene ALK and neuroblastoma.